Bank of New York Mellon Corp Invests $19.60 Million in Option Care Health, Inc. $OPCH

Bank of New York Mellon Corp purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 934,655 shares of the company's stock, valued at approximately $19,600,000. Bank of New York Mellon Corp owned approximately 0.62% of Option Care Health as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in OPCH. Royal Bank of Canada lifted its holdings in shares of Option Care Health by 20.7% in the first quarter. Royal Bank of Canada now owns 231,161 shares of the company's stock valued at $8,078,000 after purchasing an additional 39,661 shares in the last quarter. AQR Capital Management LLC boosted its position in Option Care Health by 162.6% during the 1st quarter. AQR Capital Management LLC now owns 41,633 shares of the company's stock worth $1,450,000 after acquiring an additional 25,777 shares during the period. Empowered Funds LLC acquired a new stake in Option Care Health during the 1st quarter worth about $208,000. Invesco Ltd. grew its stake in Option Care Health by 2.7% during the 2nd quarter. Invesco Ltd. now owns 294,363 shares of the company's stock valued at $9,561,000 after acquiring an additional 7,678 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company's stock valued at $46,000 after purchasing an additional 1,183 shares during the period. Institutional investors and hedge funds own 98.05% of the company's stock.

Analysts Set New Price Targets

Several analysts recently commented on OPCH shares. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a $24.00 price target (down from $26.00) on shares of Option Care Health in a report on Thursday, July 30th. Zacks Research raised shares of Option Care Health from a "strong sell" rating to a "hold" rating in a research note on Monday, July 6th. Stephens restated an "equal weight" rating and set a $24.00 price target (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. The Goldman Sachs Group initiated coverage on Option Care Health in a report on Monday, June 8th. They set a "neutral" rating and a $22.00 price objective for the company. Finally, UBS Group restated a "buy" rating on shares of Option Care Health in a research note on Tuesday, June 16th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $29.92.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $23.90 on Monday. The stock has a market capitalization of $3.58 billion, a P/E ratio of 17.97, a PEG ratio of 1.38 and a beta of 0.65. The company has a quick ratio of 0.98, a current ratio of 1.47 and a debt-to-equity ratio of 0.91. The stock has a 50 day moving average price of $22.58 and a two-hundred day moving average price of $25.17. Option Care Health, Inc. has a 12-month low of $18.01 and a 12-month high of $36.80.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, beating analysts' consensus estimates of $0.43 by $0.02. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The company's quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Equities analysts expect that Option Care Health, Inc. will post 1.69 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source